间歇性遮盖疗法强化方案与标准方案治疗儿童单眼中度弱视:随机对照试验研究方案
本研究为随机对照试验方案,拟纳入56名3至8岁伴屈光参差和/或斜视的中度弱视儿童,随机接受每日12小时间歇性遮盖疗法(IO-therapy)持续4周的强化方案或每日4小时持续12周的标准方案。主要目的是比较两种方案的有效性,次要目的包括比较依从性及探讨剂量-反应关系。
要点
- 3至8岁中度弱视儿童随机接受IO-therapy强化方案(12小时/天×4周)或标准方案(4小时/天×12周)。
- 主要结局为比较两种方案的有效性,次要结局包括依从性差异和剂量-反应关系。
- 采用微传感器剂量监测仪客观监测依从性。
核心结论
- 旨在验证每日12小时间歇性遮盖疗法持续4周的强化方案是否不劣于每日4小时持续12周的标准方案。
研究设计与样本
- 随机对照试验方案,计划纳入56名3至8岁伴屈光参差和/或斜视的中度弱视儿童。
- 所有参与者佩戴间歇性遮盖疗法眼镜(Amblyz™),设置为30秒不透明/透明交替(即50%佩戴时间遮盖)。
- 随机分为标准方案组(每日4小时,持续12周)或强化方案组(每日12小时,持续4周)。
- 采用微传感器剂量监测仪客观监测每位参与者的依从性。
关键数值与推荐
- 主要目的为比较强化方案与标准方案在3至8岁中度弱视儿童中的有效性。
- 次要目的为确定两种方案的依从性差异及间歇性遮盖疗法的剂量-反应关系。
临床怎么用
- 若强化方案被证实有效,可能改变弱视治疗策略并改善视觉结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We reported that in our previous study that wearing intermittent occlusion therapy glasses (IO-therapy) for 4 hours (h) was non-inferior to patching for 2 h in 3 to 8-year-old children with amblyopia. We hypothesize that an intense regimen of 12-h IO-therapy per day for 4 weeks could be as effective as the standard regimen of 4-h IO-therapy per day for 12 weeks in treating moderate amblyopia in 3 to 8-year-old children. METHODS/DESIGN: A total of 56 children between 3 and 8 years of age with amblyopia in association with anisometropia and/or strabismus will be enrolled. All participants will be prescribed IO-therapy glasses (Amblyz™), set at 30-s opaque/transparent intervals (i.e., occluded 50% of wear time). They will be randomized to receive the standard regimen for 12 weeks or the intense regimen for 4 weeks. Adherence to using the IO-therapy glasses will be objectively monitored in each participant by means of a microsensor dose monitor. The primary study objective is to compare the effectiveness of an intense regimen to a standard regimen of IO-therapy in 3 to 8-year-old children with moderate amblyopia. The secondary study objectives are to determine whether adherence differs between an intense regimen and a standard regimen of IO-therapy, and to determine the dose-response relationship of IO-therapy. DISCUSSION: In addition to testing the effectiveness, this study will test for the first time the association between treatment adherence and the visual outcome of IO-therapy, which will enhance our understanding of the dose-response relationship of IO-therapy. If an intense regimen is shown to be effective, it would alter amblyopia treatment strategies and improve visual outcomes. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02767856. Registered on 10 May 2016.
引用
- Wang J, Malik A, Jin J, et al. Intense versus standard regimens of intermittent occlusion therapy for unilateral moderate amblyopia in children: study protocol for a randomized controlled trial. Trials. 2020. PMID: 32345348. doi:10.1186/s13063-020-04284-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。